no photo
University Hospital of Copenhagen, Amager and Hvidovre
Dept of Infectious Diseases
no photo
Vanderbilt University Medical Center
Pediatrics, Division of Infectious Diseases
no photo
Johns Hopkins University
Epidemiology
Baylor College of Medicine
Pediatrics
Kristina G. Hulten, Ph.D., is an Associate Professor of Pediatrics at Baylor College of Medicine in Houston, TX with a joint appointment at the School for Health Professions. She is Director of the Dr. Edward O. Mason, Jr. Pediatric Infectious Disease Research Laboratory at Texas Children’s Hospital. Her main research focus concerns the pathology, antimicrobial susceptibility, epidemiology and molecular epidemiology of Staphylococcus aureus and Streptococcus pneumoniae infections. She is a co-investigator of the U.S. Pediatric Pneumococcal Surveillance Study Group. Her list of publications can be found at https://www.ncbi.nlm.nih.gov/myncbi/1LuR4zlVj7w/bibliography/public/. At Baylor College of Medicine, Dr. Hulten is also involved with Medical School Admissions, basic science classroom instruction, and she is a mentor of trainees ranging from undergraduate and graduate students to pediatric residents and fellows.
University of Bristol
Bristol Vaccine Centre, School of Population Health
Catherine Hyams graduated from the UCL MB PhD program in 2011, having undertaken her PhD under the supervision of Prof Jeremy Brown which examined the role of the polysaccharide capsule in the virulence of Streptococcus pneumoniae. She previously completed the Academic Foundation training program in North Central Thames, SHO training at St Barts and The Royal London NHS Trust, and is now completing training in Respiratory and General Medicine in the Severn Deanery, Bristol, UK. Catherine is currently a lecturer at The University of Bristol and Bristol Vaccine Centre, leading the Avon CAP study as part of The Pfizer Centre of Excellence for Epidemiology of Vaccine-preventable Diseases. Her research examines trends in respiratory infection in adults, including disease severity and factors affecting patient outcome, in addition to the effect of current and novel vaccination in modify respiratory disease.